Home Applications 076468 Application 076468
Type ANDA
Sponsor IVAX SUB TEVA PHARMS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ANAGRELIDE HYDROCHLORIDE ANAGRELIDE HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE No No 002 ANAGRELIDE HYDROCHLORIDE ANAGRELIDE HYDROCHLORIDE CAPSULE;ORAL EQ 1MG BASE No Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076468-001 ANAGRELIDE HYDROCHLORIDE ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 A076468-002 ANAGRELIDE HYDROCHLORIDE ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 13 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0172-5240 Anagrelide Hydrochloride Anagrelide Hydrochloride Teva Pharmaceuticals USA, Inc. ANDA Current 0172-5240 Anagrelide Hydrochloride Anagrelide Hydrochloride Teva Pharmaceuticals USA, Inc. ANDA Current 0172-5240 Anagrelide Hydrochloride Anagrelide Hydrochloride Teva Pharmaceuticals USA, Inc. ANDA Current 0172-5240 Anagrelide Hydrochloride Anagrelide Hydrochloride Teva Pharmaceuticals USA, Inc. ANDA Current 0172-5240 Anagrelide Hydrochloride Anagrelide Hydrochloride Teva Pharmaceuticals USA, Inc. ANDA Current 0172-5240 Anagrelide Hydrochloride Anagrelide Hydrochloride Teva Pharmaceuticals USA, Inc. ANDA Current 0172-5241 Anagrelide Hydrochloride Anagrelide Hydrochloride Teva Pharmaceuticals USA, Inc. ANDA Current 0172-5241 Anagrelide Hydrochloride Anagrelide Hydrochloride Teva Pharmaceuticals USA, Inc. ANDA Current 0172-5241 Anagrelide Hydrochloride Anagrelide Hydrochloride Teva Pharmaceuticals USA, Inc. ANDA Current 0172-5241 Anagrelide Hydrochloride Anagrelide Hydrochloride Teva Pharmaceuticals USA, Inc. ANDA Current 0172-5241 Anagrelide Hydrochloride Anagrelide Hydrochloride Teva Pharmaceuticals USA, Inc. ANDA Current 0172-5241 Anagrelide Hydrochloride Anagrelide Hydrochloride Teva Pharmaceuticals USA, Inc. ANDA Current 68151-2959 Anagrelide Hydrochloride Anagrelide Hydrochloride Carilion Materials Management ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 31125 ORIG 2005-04-28